Provided by Tiger Trade Technology Pte. Ltd.

Qiagen NV

44.75
+2.716.45%
Post-market: 43.00-1.7500-3.91%19:30 EDT
Volume:4.56M
Turnover:203.24M
Market Cap:9.22B
PE:22.75
High:45.60
Open:42.45
Low:42.18
Close:42.04
52wk High:57.82
52wk Low:32.53
Shares:206.00M
Float Shares:205.74M
Volume Ratio:1.71
T/O Rate:2.22%
Dividend:0.35
Dividend Rate:0.78%
EPS(TTM):1.97
EPS(LYR):2.04
ROE:11.93%
ROA:5.87%
PB:2.75
PE(LYR):21.91

Loading ...

Press Release: QIAGEN Reports Full Results for Q1 2026

Dow Jones
·
May 07

Qiagen NV expected to post earnings of 54 cents a share - Earnings Preview

Reuters
·
May 05

Qiagen (QGEN) Gets a Buy from DZ BANK AG

TIPRANKS
·
Apr 30

Earning Preview: Qiagen NV this quarter’s revenue is expected to increase by 6.58%, and institutional views are bullish

Earnings Agent
·
Apr 29

Baird Upgrades QIAGEN to Outperform From Neutral, Cuts Price Target to $43 From $53

MT Newswires Live
·
Apr 29

Qiagen Raised to Outperform From Neutral by Baird

Dow Jones
·
Apr 29

QIAGEN Down Over 10%, on Track for Lowest Close Since November 2019 -- Data Talk

Dow Jones
·
Apr 28

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Eli Lilly & Co (LLY) and Janux Therapeutics Inc (JANX)

TIPRANKS
·
Apr 28

Analysts Offer Insights on Healthcare Companies: Universal Health (UHS) and Qiagen (QGEN)

TIPRANKS
·
Apr 28

Qiagen cuts FY26 EPS view to ‘at least’ $2.43 from ‘at least’ $2.50

TIPRANKS
·
Apr 28

Qiagen down 5% at $36.11 after Q1 pre-announcement, FY26 guidance cut

TIPRANKS
·
Apr 28

Press Release: QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook

Dow Jones
·
Apr 28

Unusually active option classes on open April 27th

TIPRANKS
·
Apr 27

How Investors May Respond To Qiagen (QGEN) Entering Rapid Bloodstream Infection Testing With New Panel

Simply Wall St.
·
Apr 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tandem Diabetes Care (TNDM) and Qiagen (QGEN)

TIPRANKS
·
Apr 15

Qiagen expands into bloodstream infection syndromic testing

TIPRANKS
·
Apr 15

Is Qiagen (QGEN) Offering Value After Mixed Share Price Performance?

Simply Wall St.
·
Apr 14

Qiagen price target raised to EUR 44 from EUR 43 at Morgan Stanley

TIPRANKS
·
Apr 14

Qiagen Cut to Equal-Weight From Overweight by Barclays

Dow Jones
·
Apr 14

Barclays Downgrades QIAGEN to Equalweight From Overweight, Adjusts Price Target to $44 From $48

MT Newswires Live
·
Apr 14